Related Experiment Video
Updated: Jul 9, 2026
07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
13.8K
Molecular Biomarkers of Bladder Cancer: A Mini-Review
Z Varchulová Nováková1, M Kuniaková, S Žiaran
1Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. zuzana.varchulova@fmed.uniba.sk.
Physiological Research
|October 27, 2023
Summary
Molecular markers offer new hope for early bladder cancer diagnosis and personalized treatment. This research explores their potential for precise diagnostics and novel nanomaterial-based therapies.
Area of Science:
- Oncology
- Biotechnology
Background:
- Bladder cancer is a common and serious malignancy with complex diagnostic and therapeutic challenges.
- Current prognostic markers lack reliability in predicting disease course and treatment response.
- Molecular markers present an opportunity for early detection and personalized treatment strategies.
Conclusions:
- Molecular markers are crucial for improving bladder cancer diagnostics and patient management.
- Integrating molecular diagnostics with innovative therapies like nanomaterials can enhance treatment outcomes.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...